Stock Events

Stock Events

HST Global 

$0.63
1
+$0+0% Thursday 17:41

Statistics

Day High
0.63
Day Low
0.63
52W High
1.05
52W Low
0
Volume
100
Avg. Volume
300
Mkt Cap
36.11M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.02
-0.01
-0.01
-0.01
Expected EPS
N/A
Actual EPS
-0.0067

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-451,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HSTC. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology firm involved in the development of treatments that could potentially compete with HST Global's cancer therapies.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences operates in the biopharmaceutical field focusing on drugs, including cancer treatments, which could directly compete with HST Global's products.
Merck
MRK
Mkt Cap214.76B
Merck is a global healthcare company that produces cancer drugs and therapies, competing in the same market as HST Global.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is involved in the development and manufacturing of healthcare products, including cancer treatments, which positions them as a competitor to HST Global.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb specializes in biopharmaceuticals, including cancer drugs, competing in the oncology sector with HST Global.
Novartis
NVS
Mkt Cap237.61B
Novartis is a multinational pharmaceutical company that develops and sells drugs, including those for cancer, which competes with HST Global's offerings.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company develops pharmaceutical products, including cancer treatments, which makes them a direct competitor to HST Global.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the healthcare sector, offering products and treatments for various diseases, including cancer, competing with HST Global.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie is a biopharmaceutical company that develops and markets therapies, including for cancer, which competes with HST Global.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a major player in diagnostics and pharmaceuticals, including cancer treatments, directly competing with HST Global in the oncology market.

About

HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.
Show more...
CEO
Mr. Mike Field
Country
US
ISIN
US40432E2028

Listings

OTC Link
US
HSTC

0 Comments

Share your thoughts

FAQ

What is HST Global stock price today?▼
The current price of HSTC is $0.63 USD — it has increased by +0% in the past 24 hours. Watch HST Global stock price performance more closely on the chart.
What is HST Global stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange HST Global stocks are traded under the ticker HSTC.
Is HST Global stock price growing?▼
HSTC stock has risen by +0% compared to the previous week, the month change is a +25% rise, over the last year HST Global has showed a -24.7% decrease.
What is HST Global market cap?▼
Today HST Global has the market capitalization of 36.11M
What were HST Global earnings last quarter?▼
HSTC earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is HST Global revenue for the last year?▼
HST Global revenue for the last year amounts to 0 USD.
What is HST Global net income for the last year?▼
HSTC net income for the last year is -451,000 USD.
In which sector is HST Global located?▼
HST Global operates in the Health Care sector.
When did HST Global complete a stock split?▼
The last stock split for HST Global was on November 26, 2019 with a ratio of 1:15.
Where is HST Global headquartered?▼
HST Global is headquartered in Virginia Beach, US.